Other
ctDNA test
ctDNA test is an intervention with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Other(3)
Detailed Status
unknown3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (100.0%)
Trials by Status
recruiting125%
unknown375%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
NCT06640283
unknown
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372
unknown
ctDNA for Prediction of Relapse in Gastric Cancer
NCT02887612
unknown
The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer
NCT03416478
Clinical Trials (4)
Showing 4 of 4 trials
NCT06640283Phase 2
Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
NCT05208372
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT02887612
ctDNA for Prediction of Relapse in Gastric Cancer
NCT03416478
The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4